Check out our most popular compounded medications! Get Started
The Anastrozole 0.1 mg Polyglycol Troche is a square-shaped solid dosage form that dissolves slowly in the mouth. It delivers medication through oral mucosa absorption for targeted local or systemic effects. This formulation is used in the treatment of various types of cancer, including breast, endometrial, prostate, uterine, and ovarian cancer.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Anastrozole 0.1 mg Polyglycol Troche is a specially compounded medication, primarily used as an aromatase inhibitor. It functions by inhibiting the production of estrogen in the body, which can be beneficial in treating a variety of conditions such as breast cancer, endometriosis, and uterine fibroids. Additionally, it can be used to reduce the risk of recurrence in patients who have previously undergone treatment for breast cancer.
This medication is presented in a square-shaped solid dosage form, designed to dissolve slowly in the mouth. The troche delivers the medication through absorption via the oral mucosa, allowing for targeted local or systemic effects. This method of delivery is not only convenient but also ensures quick and efficient absorption of the medication, providing prompt relief from symptoms.
Anastrozole 0.1 mg Polyglycol Troche can provide significant relief from symptoms associated with the aforementioned disease states. It also plays a crucial role in reducing the risk of recurrence in patients who have been treated for breast cancer. It is of utmost importance to adhere to the instructions provided by your healthcare provider when taking this medication.
It is crucial to consider the patient's medical history and any other medications they may be taking before prescribing this medication.
If you have any queries regarding Anastrozole 0.1 mg Polyglycol Troche, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is equipped with the knowledge and expertise to assist you.
Anastrozole 0.1 mg Polyglycol Troche is a square-shaped solid dosage form that is designed to dissolve slowly in the mouth. This unique delivery method allows the medication to be absorbed through the oral mucosa, providing targeted local or systemic effects. This formulation of Anastrozole is primarily used for the treatment of advanced breast cancer in postmenopausal women. It is also utilized to decrease the risk of breast cancer recurrence in postmenopausal women who have previously undergone treatment with tamoxifen.
Anastrozole functions by inhibiting the production of estrogen, a hormone that can stimulate the growth of certain types of breast cancer cells. However, it is crucial to understand that Anastrozole is not suitable for the treatment of premenopausal women or men.
When using Anastrozole 0.1 mg Polyglycol Troche, it is essential to be mindful of potential drug interactions. Anastrozole may interact with specific medications, including warfarin, phenytoin, and tamoxifen. Awareness of potential side effects is also important, which may encompass hot flashes, joint pain, nausea, and fatigue.
It is of utmost importance to take Anastrozole 0.1 mg Polyglycol Troche exactly as prescribed by your healthcare provider. Do not alter the dosage without professional medical advice. If you have any queries or concerns regarding the use of this medication, it is recommended to consult with your healthcare provider or pharmacist.
Anastrozole 0.1 mg Polyglycol Troche is a specially compounded medication primarily used in the treatment of conditions such as breast cancer, endometriosis, and uterine fibroids. Its mechanism of action involves the inhibition of estrogen production, a hormone that can potentially stimulate the growth of certain cancer cells. The unique polyglycol troche delivery system ensures a slow and steady release of the medication, thereby providing a more consistent and sustained therapeutic effect.
Patients are advised to take Anastrozole 0.1 mg Polyglycol Troche as prescribed by their healthcare provider. Adherence to the prescribed dosage is crucial for the medication's effectiveness. It is equally important to inform your doctor about any other medications you are currently taking, as potential interactions may occur with Anastrozole 0.1 mg Polyglycol Troche.
Regular monitoring of patients for any side effects, such as nausea, vomiting, or changes in appetite, is recommended. If any of these side effects occur, dosage adjustments or a switch to an alternative medication may be necessary.
If you have any queries or concerns regarding Anastrozole 0.1 mg Polyglycol Troche, please do not hesitate to contact us. We are committed to providing the best possible treatment options for your patients.
Anastrozole 0.1 mg Polyglycol Troche is a square-shaped solid dosage form of the medication Anastrozole. It is designed to dissolve slowly in the mouth, delivering the medication through absorption by the oral mucosa for targeted local or systemic effects.
This medication works by slowly dissolving in the mouth and being absorbed through the oral mucosa. This allows for the medication to be delivered directly into the bloodstream, bypassing the digestive system, for targeted local or systemic effects.
You should place the troche in your mouth and allow it to dissolve slowly. Do not chew or swallow the troche whole. The medication is designed to be absorbed through the oral mucosa in your mouth.
As with any medication, Anastrozole 0.1 mg Polyglycol Troche can have side effects. These can include dry mouth, changes in taste, or irritation in the mouth where the troche is placed. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
It's important to tell your healthcare provider about all the medications you're currently taking, as some may interact with Anastrozole. Your healthcare provider will be able to advise you on whether it's safe to take this medication with others.
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
Store this medication at room temperature, away from heat and direct light. Do not freeze the medication, and keep it out of the reach of children.
If you accidentally swallow the troche, drink a glass of water and contact your healthcare provider. The medication is designed to be absorbed through the oral mucosa, not the digestive system, so swallowing it may reduce its effectiveness.
It's best to avoid eating or drinking while the troche is dissolving in your mouth. This can interfere with the absorption of the medication. Once the troche has completely dissolved, you can eat or drink as normal.
It's important to tell your healthcare provider if you're pregnant, planning to become pregnant, or breastfeeding. They will be able to advise you on whether it's safe to take this medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve
